Fig. 7.
Fig. 7. Human engraftment of secondary recipients by BM from a primary recipient of human CD34+ cells. (A) Histograms of BM, spleen, and PB cells stained with antibodies against both mu and hu CD45. All secondary recipients from experiments 1 and 7 contained huCD45+ cells in these tissues. (B) Typical profiles of the myeloid, lymphoid, and progenitor cells comprising the huCD45+ cell fraction of mouse BM are illustrated with histograms from the BM of a secondary recipient. Mouse BM cells were triple-stained and cells within the huCD45+ gate were analyzed. Populations of myeloid progenitors (CD33+, 2.3%), early myeloid cells (CD13+/33+, 11.3%), more mature myeloid cells (CD13+, 9.5%), monocytes (CD14+, 8%), and B cells (CD19+, 63%) were observed, while a significant proportion (5.5%) of huCD45+ BM cells expressed CD34.

Human engraftment of secondary recipients by BM from a primary recipient of human CD34+ cells. (A) Histograms of BM, spleen, and PB cells stained with antibodies against both mu and hu CD45. All secondary recipients from experiments 1 and 7 contained huCD45+ cells in these tissues. (B) Typical profiles of the myeloid, lymphoid, and progenitor cells comprising the huCD45+ cell fraction of mouse BM are illustrated with histograms from the BM of a secondary recipient. Mouse BM cells were triple-stained and cells within the huCD45+ gate were analyzed. Populations of myeloid progenitors (CD33+, 2.3%), early myeloid cells (CD13+/33+, 11.3%), more mature myeloid cells (CD13+, 9.5%), monocytes (CD14+, 8%), and B cells (CD19+, 63%) were observed, while a significant proportion (5.5%) of huCD45+ BM cells expressed CD34.

Close Modal

or Create an Account

Close Modal
Close Modal